GYRE Gyre Therapeutics, Inc. - Common Stock
$7,21
Prix · Aoû 19, 2026
Données fondamentales au Aoû 7, 2026
Fourchette 52 semaines
$5–$9
44% of range
Note des analystes
BUY
9 analysts
Objectif de cours
$19
+159% upside
P/E (TTM)
360.2
ROE
11.7%
Marge nette
8.5%
GYRE Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$7.21
Capitalisation Boursière
$658M
P/E (TTM)
360.2
BPA (TTM)
$0.02
Revenus (TTM)
$117M
Rendement div.
—
ROE
11.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$5 – $9
GYRE Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$117M
2017-12-31
→
2025-12-31
BPA
$0.02
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-180.0K
2016-12-31
→
2025-12-31
Marges
8.5%
2023-12-31
→
2024-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
GYRE
Médiane des pairs
P/E (TTM)
360.2
19.6
P/S (TTM)
5.6
6.4
P/B
6.2
2.6
Price / FCF (Cours / FCF)
-3655.1
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
GYRE
Médiane des pairs
Operating Margin (Marge d'exploitation)
9.8%
—
Net Profit Margin (Marge nette)
8.5%
-104.2%
ROA
6.8%
-40.3%
ROE
11.7%
-42.4%
ROIC
7.4%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
GYRE
Médiane des pairs
Current Ratio (Ratio de liquidité)
5.6
5.4
Quick Ratio (Ratio de liquidité réduite)
4.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
GYRE
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
10.2%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
4.5%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
41.0%
—
EPS YoY (BPA Année/Année)
-60.0%
—
Net Income YoY (Bénéfice net YoY)
-44.8%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
GYRE
Médiane des pairs
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
—
Ratio de distribution
—
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 13 janvier 2023 | $3,6000 |
| 21 septembre 2022 | $21,4500 |
| 20 août 2015 | $896,1750 |
GYRE Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
9 analystes
- Achat fort 3 33,3%
- Achat 5 55,6%
- Conserver 1 11,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
3 analystes · 2026-08-14
Médiane
$18.00
Moyenne
$18.67
← En dessous de tous les objectifs
$7.21
Bas
$18.00
Haut
$20.00
Objectif médian
$18.00
+149,8%
Objectif moyen
$18.67
+159,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.12 | $-0.09 | -0.03% |
| 31 mars 2026 | $-0.04 | $-0.07 | 0.03% |
| 31 décembre 2025 | $0.05 | $0.06 | -0.01% |
| 30 septembre 2025 | $0.08 | $0.03 | 0.05% |
| 30 juin 2025 | $0.02 | $0.03 | -0.01% |
| 31 mars 2025 | $0.03 | $0.03 | -0.00% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Taux de croissance 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | -177,045,292 | 90,850,040 | 89,119,344 | 86,420,530 | -169,316,980 | 85,643,646 | 85,502,403 | 83,265,879 | -124,932,682 | 63,588,119 | 63,588,119 | 63,588,119 | -30,829,566 | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | -205,463,888 | 103,971,546 | 89,203,138 | 101,970,672 | -205,146,932 | 102,640,373 | 102,205,888 | 102,594,197 | -170,898,339 | 78,904,324 | 78,904,324 | 78,921,366 | -18,737,151 | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Flux de trésorerie 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $102M | · | $105M | $100M | $100M | · | $110M | $114M | $113M | · | · | · | · | · | $6M | |
| Net Income TTM | $-29M | $1M | · | $14M | $13M | $21M | · | $25M | $26M | $25M | · | $11M | $55M | $36M | · | $7M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -99.6 | · | 186.5 | 367.5 | 154.4 | · | 125.4 | 108.5 | 134.5 | · | -120.0 | 3.4 | 3.0 | · | 34.1 | |
| P/S | · | 6.2 | · | 6.5 | 6.7 | 6.8 | · | 9.8 | 9.0 | 13.2 | · | · | · | · | · | 41.5 | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| P / FCF | · | 212.1 | · | · | · | -2695.4 | · | · | · | 562.8 | · | · | · | · | · | · | |
| Earnings Yield | -3.3% | -1.0% | · | 0.54% | 0.27% | 0.65% | · | 0.80% | 0.92% | 0.74% | · | -0.83% | 29.1% | 33.3% | · | 2.9% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $117M | $106M | $113M | $102M | $7M |
| Marge Brute % | — | 96.3% | 95.9% | — | — |
| Marge d'exploitation % | 9.8% | 15.3% | -59.3% | — | — |
| Résultat net | $10M | $18M | $-85M | $4M | $-88M |
| BPA dilué | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 5.6 | 3.3 | 2.9 | 1.7 | — |
| Ratio de liquidité réduite | 4.6 | 2.4 | 1.7 | 1.3 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-180.0K | $-6M | $17M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 63 déclarants · $55.4M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 17 (+6 vs T. préc.) | 7 (+4 vs T. préc.) | 26 (+8 vs T. préc.) | 8 (0 vs T. préc.) | +6.1M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| HSG Holding Ltd | $24 714 470 | 3 750 299 | 44,65% | Actions |
| VANGUARD GROUP INC | $7 437 901 | 1 053 527 | 13,44% | Actions |
| Octagon Capital Advisors LP | $6 289 601 | 954 416 | 11,36% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 778 949 | 876 927 | 10,44% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $3 006 906 | 456 126 | 5,43% | Actions |
| STATE STREET CORP | $1 617 199 | 245 402 | 2,92% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 214 445 | 184 286 | 2,19% | Actions |
| SBI Securities Co., Ltd. | $1 098 883 | 166 750 | 1,99% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $995 571 | 151 073 | 1,80% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816 850 | 123 953 | 1,48% | Actions |
| GOLDMAN SACHS GROUP INC | $568 289 | 86 235 | 1,03% | Actions |
| Bank of New York Mellon Corp | $227 935 | 34 588 | 0,41% | Actions |
| ALLIANCEBERNSTEIN L.P. | $171 392 | 24 590 | 0,31% | Actions |
| STRS OHIO | $170 022 | 25 800 | 0,31% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $161 521 | 24 510 | 0,29% | Actions |
| Nuveen, LLC | $161 488 | 24 505 | 0,29% | Actions |
| MILLENNIUM MANAGEMENT LLC | $121 836 | 18 488 | 0,22% | Actions |
| RHUMBLINE ADVISERS | $111 131 | 16 865 | 0,20% | Actions |
| FMR LLC | $98 679 | 14 974 | 0,18% | Actions |
| BANK OF AMERICA CORP /DE/ | $82 539 | 12 525 | 0,15% | Actions |
| Polymer Capital Management (US) LLC | $77 630 | 11 780 | 0,14% | Actions |
| Vanguard Global Advisers, LLC | $65 788 | 9 983 | 0,12% | Actions |
| Police & Firemen's Retirement System of New Jersey | $59 382 | 9 011 | 0,11% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55 659 | 8 446 | 0,10% | Actions |
| CITIGROUP INC | $49 603 | 7 527 | 0,09% | Actions |
| BlackRock, Inc. | $28 752 | 4 363 | 0,05% | Actions |
| Russell Investments Group, Ltd. | $23 803 | 3 612 | 0,04% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $22 973 | 3 486 | 0,04% | Actions |
| NORTHERN TRUST CORP | $18 887 | 2 866 | 0,03% | Actions |
| BARCLAYS PLC | $18 558 | 2 816 | 0,03% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $17 793 | 2 700 | 0,03% | Actions |
| Tower Research Capital LLC (TRC) | $16 271 | 2 469 | 0,03% | Actions |
| MORGAN STANLEY | $16 106 | 2 444 | 0,03% | Actions |
| Legal & General Group Plc | $13 536 | 2 054 | 0,02% | Actions |
| Ameritas Investment Partners, Inc. | $4 501 | 683 | 0,01% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 454 | 639 | 0,01% | Actions |
| ROYAL BANK OF CANADA | $4 000 | 537 | 0,01% | Actions |
| Activest Wealth Management | $3 512 | 533 | 0,01% | Actions |
| Arax Advisory Partners | $1 621 | 246 | 0,00% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $1 285 | 195 | 0,00% | Actions |
| Sterling Capital Management LLC | $1 061 | 161 | 0,00% | Actions |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Actions |
| CWM, LLC | $725 | 104 | 0,00% | Actions |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Actions |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Actions |
| WELLS FARGO & COMPANY/MN | $435 | 66 | 0,00% | Actions |
| JPMORGAN CHASE & CO | $361 | 56 | 0,00% | Actions |
| GoalVest Advisory LLC | $330 | 50 | 0,00% | Actions |
| Allworth Financial LP | $251 | 38 | 0,00% | Actions |
| DEUTSCHE BANK AG\ | $244 | 37 | 0,00% | Actions |
| OSAIC HOLDINGS, INC. | $216 | 33 | 0,00% | Actions |
| UBS Group AG | $165 | 25 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $100 | 15 031 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $99 | 15 | 0,00% | Actions |
| Integrated Wealth Concepts LLC | $94 | 14 | 0,00% | Actions |
| EverSource Wealth Advisors, LLC | $53 | 8 | 0,00% | Actions |
| Farther Finance Advisors, LLC | $53 | 8 | 0,00% | Actions |
| Optiver Holding B.V. | $40 | 6 | 0,00% | Actions |
| Smartleaf Asset Management LLC | $39 | 6 | 0,00% | Actions |
| State of Alaska, Department of Revenue | $34 | 5 219 | 0,00% | Actions |
| ROTHSCHILD INVESTMENT LLC | $7 | 1 | 0,00% | Actions |
| Essential Partners LLC | $7 | 1 | 0,00% | Actions |
| Covestor Ltd | $0 | 48 | 0,00% | Actions |
Initiés de la société 66 initiés · 26 dirigeants · 32 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 8 juin 2026 A | 2 565 226 | 0 | 2 | $-82 927 |
| Han Ying | Chief Executive Officer | 14 août 2024 A | — | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 novembre 2023 A | — | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 4 mai 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 4 mai 2026 A | 15 000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 7 janvier 2026 A | — | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 août 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 8 février 2021 A | — | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 août 2019 A | 3 744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 août 2015 A | 1 159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 octobre 2014 A | 57 799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 mai 2025 S | 2 806 084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 juin 2026 M | 700 000 | 0 | 16 | $-869 947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 8 juin 2026 A | — | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 9 août 2022 P | 9 417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 9 août 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 mars 2020 P | 7 353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 octobre 2015 A | 31 008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 août 2015 A | 45 000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 octobre 2014 A | 46 000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 janvier 2014 A | — | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 janvier 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 janvier 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 janvier 2013 A | 15 938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 septembre 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 mars 2011 A | 1 153 | 0 | 0 | $0 |
| Claire Weston | Administrateur | 3 août 2026 A | — | 0 | 0 | $0 |
| Maxwell Kirkby | Administrateur | 3 août 2026 A | — | 0 | 0 | $0 |
| Dan Weng | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| Ping Zhang | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| Rodney L Nussbaum | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| Renate Parry | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| Gordon Carmichael | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| David M. Epstein | Administrateur | 10 juin 2026 A | — | 0 | 0 | $0 |
| Nassim Usman | Administrateur | 28 juin 2024 M | 1 636 | 0 | 0 | $0 |
| Andrea Hunt | Administrateur | 31 août 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Administrateur | 31 août 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Administrateur | 7 janvier 2022 A | 31 790 | 0 | 0 | $0 |
| Eddie Williams | Administrateur | 7 janvier 2022 A | 34 804 | 0 | 0 | $0 |
| Errol B Desouza | Administrateur | 1 octobre 2021 A | 29 801 | 0 | 0 | $0 |
| Jeanne Y Jew | Administrateur | 9 septembre 2021 A | — | 0 | 0 | $0 |
| Sharon Tetlow | Administrateur | 9 juin 2021 A | 3 635 | 0 | 0 | $0 |
| John P Richard | Administrateur | 13 mars 2020 P | 3 716 | 0 | 0 | $0 |
| Stephen A Hill | Administrateur | 6 septembre 2018 D | 1 190 | 0 | 0 | $0 |
| Harold E Selick | Administrateur | 16 janvier 2018 A | 16 614 | 0 | 0 | $0 |
| Jeff Himawan | Administrateur | 20 août 2015 J | 1 179 352 | 0 | 0 | $0 |
| Alan W Dunton | Administrateur | 14 août 2015 A | 10 000 | 0 | 0 | $0 |
| Charles A Blixt | Administrateur | 14 août 2015 A | 10 000 | 0 | 0 | $0 |
| Julia R Brown | Administrateur | 14 août 2015 A | 10 000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Administrateur | 7 juin 2013 A | 11 332 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 21 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 7 mai 2026 | 6,33% | Amendement | Fusions et acquisitions / vente | SEC |
| Ying Luo, Ping Lan | 6 mai 2026 | 8,60% | Amendement | Fusions et acquisitions / vente | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 dépôts | 6 mai 2026 | 69,10% | Amendement | Fusions et acquisitions / vente | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 6 septembre 2024 | — | Dépôt initial | Investissement passif | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 6 septembre 2024 | — | Dépôt initial | Investissement passif | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 dépôts | 31 octobre 2023 | — | Dépôt initial | — | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 dépôts | 7 octobre 2022 | — | Dépôt initial | Investissement passif | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 dépôts | 22 septembre 2022 | — | Dépôt initial | — | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 dépôts | 27 janvier 2022 | — | Dépôt initial | — | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 dépôts | 5 août 2020 | — | Dépôt initial | — | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 dépôts | 17 janvier 2020 | — | Dépôt initial | — | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 février 2018 | — | Dépôt initial | — | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 dépôts | 9 février 2018 | — | Dépôt initial | — | SEC |
| 23 mai 2017 | — | Dépôt initial | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 dépôts | 29 mars 2017 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 18 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 117 803 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,00% | 386 378 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,00% | 5 185 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 99 892 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 41 237 SH | 8 août 2026 | Quotidien |
| ITWO · ProShares Trust | 0,00% | 555 NS | 31 mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 435 NS | 31 mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 441 NS | 31 mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 907 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 11 NS | 31 mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18 000 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238 693 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614 654 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104 607 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 047 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 494 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 30 avril 2026 | N-PORT |